Shelley B. Thunen, Chief Financial Officer at RxSight, Inc. (RXST), sold 36,804 shares at $58.41 ($2.2M) on 2024-07-01, disclosed to the SEC on 2024-07-02.
Scheduled sale ($2.2M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.41 | 8,146 | $476K | 22.0% |
| 2 | $58.41 | 8,146 | $476K | 22.0% |
| 3 | $58.55 | 6,599 | $386K | 17.9% |
| 4 | $58.55 | 6,599 | $386K | 17.9% |
| 5 | $59.48 | 1,854 | $110K | 5.1% |
| 6 | $59.48 | 1,854 |
| $110K |
| 5.1% |
| 7 | $59.56 | 1,803 | $107K | 5.0% |
| 8 | $59.56 | 1,803 | $107K | 5.0% |
| Total | $58.68 avg | 36,804 | $2.2M | 100% |
| Filing → |
| RXST | SELL | 2024-04-02 | $1.9M | — | Filing → |
| RXST | SELL | 2024-03-05 | $1.1M | — | Filing → |
| RXST | SELL | 2024-02-07 | $2.4M | — | Filing → |